Dr. Advani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10201 Carnegie Avenue
Desk CA60
Cleveland, OH 44195Phone+1 216-445-9354Fax+1 216-444-9464
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1999 - 2002
- Duke University HospitalResidency, Internal Medicine, 1996 - 1999
- Duke University School of MedicineClass of 1996
Certifications & Licensure
- OH State Medical License 2002 - 2025
- NC State Medical License 1997 - 2003
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia Start of enrollment: 2003 Jul 01
- Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia Start of enrollment: 2006 Jan 01
- S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Start of enrollment: 2006 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 125 citationsCBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemiaHideki Makishima, Anna M. Jankowska, Michael A. McDevitt, Christine L. O'Keefe, Simon Dujardin
Blood. 2011-05-26 - 103 citationsPhase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies.Stephen M. Ansell, Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn
Clinical Cancer Research. 2021-04-15 - 157 citationsPrognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.Ramon V. Tiu, Lukasz P. Gondek, Christine L. O'Keefe, Paul Elson, Jungwon Huh
Blood. 2011-04-28
Journal Articles
- A Phase 1 Trial of Vadastuximab Talirine Combined with Hypomethylating Agents in Patients with CD33 Positive AMLEytan M Stein, Anand Jillella, Anthony S Stein, Amir T Fathi, Roland B Walter, Jeffrey E Lancet, Tibor J Kovacsovics, Anjali S Advani, Phoenix A Ho, Dale Bixby, Blood
Abstracts/Posters
- Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?Anjali S. Advani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Double-Blind, Placebo-Controlled, Phase 3 Registration Trial to Evaluate the Efficacy of Uproleselan (GMI-1271) with Standard Salvage Chemotherapy in Patients with R...Anjali S. Advani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- ANKRD26 Coding Variants Presenting with Giant Platelets and a Predisposition to Myeloid NeoplasiaAnjali S. Advani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Acute Lymphoblastic Leukemia: Aiming High to Keep MRD Low, or Even Better, Negative61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Genomic Biomarkers Predict Response/Resistance to Lenalidomide in Non-Del(5q) Myelodysplastic Syndromes2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Ponatinib Linked with Better Outcomes Than Imatinib in Philadelphia Chromosome-Positive ALLMarch 17th, 2023
- New Treatment Combination Without Chemotherapy Is Effective in PH+ Acute Lymphoblastic LeukemiaDecember 13th, 2021
- Addition of Ixazomib to MEC Chemotherapy Promising in R/R AMLAugust 30th, 2019
- Join now to see all
Professional Memberships
- Member
- Member
- SWOGMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: